Evaluation of eligibility and recruitment in breast cancer clinical trials

Breast. 2014 Aug;23(4):385-92. doi: 10.1016/j.breast.2014.02.002. Epub 2014 Mar 26.

Abstract

Objectives of the study were to measure recruitment rates in clinical trials and to identify patients, physicians or trials characteristics associated with higher recruitment rates. Among patients who had a clinical trial available for their cancer, 83.5% (345/413) met the eligibility criteria to at least one clinical trial. At least one trial was proposed to 33.1% (113/341) of the eligible patients and 19.7% (68/345) were recruited. Overall recruitment was 16.5% (68/413). In multivariate analyses, trial proposal and enrollment were lower for elderly patients and higher in high cancer stages. Trials from pharmaceutical industry had higher recruitment rates and trials testing hormonal therapy enrolled more patients. Breast cancer patients' accrual to a clinical trial could be improved by trying to systematically identify all eligible patients and propose a trial to those eligible and to whom the treatment is planned to be equivalent to the standard arm of the trial.

Keywords: Breast cancer; Clinical trials; Eligibility; Patient recruitment.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Clinical Trials as Topic*
  • Cohort Studies
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Patient Selection*
  • Retrospective Studies
  • Young Adult